治疗高风险的骨髓分裂性综合征
Yishan Ye1,2, Eolia Brissot2, Ali Bazarbachi3
1Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Bone marrow transplantation
|March 6, 2026
概括
较高风险的骨髓分裂性综合征 (HR-MDS) 管理涉及风险分层和标准低甲基化剂. 新型疗法有前途,但需要进一步的研究来改善这一老年患者群体的生存结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 内部医学 内部医学
背景情况:
- 高风险骨髓发育综合征 (HR-MDS) 是影响老年人的复杂血液癌症.
- 血细胞生产效率低下,血细胞计数低,以及急性髓性白血病转变风险的特征.
研究的目的:
- 审查当前的HR-MDS管理策略.
- 讨论风险分层,治疗选择和HR-MDS护理中的挑战.
主要方法:
- 使用国际预测评分系统 (IPSS-R和IPSS-M) 进行风险分类.
- 审查低甲基化剂和新型治疗剂的疗效.
- 讨论了全源性造血干细胞移植作为治愈选择.
主要成果:
- 低甲基化剂是标准的,但提供有限的存活 (13-19个月).
- 新型药物 (venetoclax,突变向药物) 显示出早期的希望,但第三阶段试验尚未完成.
- 异构干细胞移植具有治愈作用,但受患者因素的限制.
结论:
- 人力资源-MDS管理需要基于风险分层的定制方法.
- 组合疗法和新药需要进一步研究.
- 未来的研究应该专注于突变特异性治疗和包容性临床试验.
相关概念视频
Bone Marrow Sampling and Transplants
2.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.0K
Stem Cell Therapy for Tissue Regeneration
4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K


